Back
CUV
Clinuvel Pharmaceuticals Limited
๐ฆ๐บ ASX
๐งฌ BIOTECHNOLOGY
๐ Overview
๐ Performance
๐ฐ Dividends
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-8.87%
Annual Growth
5 years average annual capital growth
๐ฐ
0.34%
Annual dividend yield
Based on the most recent dividend
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
22
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Companyโs pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).
๐ Performance
Price History
+417.20%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ฐ Dividends
Payouts
๐ฐ Annual Dividend Yield*
0.34%
๐ฐ Annual Dividend Earnings Per $1,000 invested**
$3.37
๐ฐ Most Recent Dividend Franked Percentage Estimate
100.00%
๐ฐ Average Dividend Franked Percentage Estimate
100.00 %
๐ฐ Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of CUV, your last dividend payment(s) would have been:
$ 47.02
on Fri Sep 20 2024
$ 39.35
on Wed Sep 20 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.05
Infinity%
2022
$0.04
Infinity%
2021
$0.03
Infinity%
2020
$0.03
NaN%
2019
$0.03
NaN%
2018
$0.02
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ Environmental, Social and Governance scores โน๏ธ
๐ณ
Environmental Score
2
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
โ๏ธ
Governance Score
39
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
๐ค Advanced information
Technical Info
๐ฐ Price*
$12.93
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in CUV
21
๐ Total Capital Earnings
$8K
๐ Average investment frequency
18 weeks
๐ต Average investment amount
$8,998
โฐ Last time a customer invested in CUV
12 hours
CUV investor breakdown
๐ต Income of investors
More than 200k
6%
150k - 200k
13%
100k - 150k
6%
50k - 100k
39%
Less than 50k
32%
๐ถ Age of investors
18 - 25
14%
26 - 34
24%
35 - 90
62%
๐ Legal gender of investors
Female
19%
Male
81%
Pearlers who invest in CUV also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
8.48%
๐ Share price
$111.36 AUD
๐ฆ๐บ AUSTRALIA
๐ธ FINANCIALS
๐งฑ MATERIALS
โณ๏ธ DIVERSIFIED
๐ HIGH PRICE GROWTH
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. The company is headquartered in Sydney, New South Wales and currently employs 42,000 full-time employees. The firm is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The firm operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The firm's provides services to clinicians, hospitals, community health services, and their patients. The firm has more than 120 radiology centers.
๐ Performance (5Yr p.a)
-5.73%
๐ Share price
$24.60 AUD
๐๏ธ SOCIALLY AWARE
๐ณ ENVIRONMENTAL
๐ฉบ HEALTH CARE
RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 9,980 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
๐ Performance (5Yr p.a)
15.34%
๐ Share price
$44.69 AUD
๐ฉบ HEALTH CARE
๐ณ ENVIRONMENTAL
๐๏ธ SOCIALLY AWARE
๐ HIGH PRICE GROWTH
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
๐ Performance (5Yr p.a)
19.56%
๐ Share price
$53.03 AUD
๐ค TECHNOLOGY
๐ HIGH PRICE GROWTH
๐บ๐ธ UNITED STATES
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
๐ Performance (5Yr p.a)
21.63%
๐ Share price
$66.11 AUD
๐บ๐ธ UNITED STATES
๐ HIGH PRICE GROWTH
Want more shares? Try these...
๐๏ธ
Social Score
61
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.